Published on 14 April 2024
November 8, 2024
A landmark collaboration between ESGAR, ARGANZ, ASAR and SAR, we invite you to attend this one-day global virtual event dedicated to hepatocellular carcinoma (HCC). The agenda encompasses a comprehensive exploration of HCC, including discussions on its global impact and burden, pathophysiology, multimodality imaging assessment for screening, staging, and treatment response evaluation, as well as systemic and interventional radiology image-guided therapies. Distinguished speakers from all five continents will contribute to deepening your understanding of abdominal imaging and foster a spirit of international collaboration among radiologists to improve the lives of patients globally. For more details click here.